Seattle Genetics Commits To Simultaneous Confirmatory Trials For Adcetris
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA approves the antibody-drug conjugate for late stage Hodgkins lymphoma and systemic anaplastic large cell lymphoma Aug. 19.